Some Things that You Should Know Regarding Bipolar Depression
The bipolar disorder is a kind of condition which affects all types of people. Children and adults are affected by this condition. This is one fact that you must understand. Those women would suffer the most from such type of depression which is known as bipolar depression disorder.
This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not just women are depressive but the men would also get affected by such kind of condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It is surely not flattering to either of you when you get treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. When such efficacy would be proven as monotherapy, the new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.